Research Article
Analysis of the Clinicopathologic Characteristics and Prognosis of Head and Neck Lymphoma
Table 1
Primary antibodies and conditions used for immunohistochemical staining.
| | Antigen | Clone | Source | Dilution | Positive location |
| | ALK | SP8 | ZSBIO | 1 : 80 | Nuclei/cytoplasm | | Bcl-2 | 100/D5 | Shanghai Long Island | 1 : 100 | Cytoplasm | | Bcl-6 | GI191E/A8 | ZSBIO | 1 : 80 | Nuclei | | CD3 | UCHT1 | Shanghai Long Island | 1 : 50 | Cytoplasm/cytomembrane | | CD5 | SP19 | ZSBIO | 1 : 100 | Cytomembrane | | CD8 | SP16 | ZSBIO | 1 : 100 | Cytomembrane | | CD10 | 56C6 | Gene Company | 1 : 50 | Cytomembrane | | CD20 | L26 | Dako | 1 : 150 | Cytomembrane | | CD30 | Ber-H2 | MXBIO | 1 : 100 | Cytomembrane/cytoplasm | | CD43 | DF-T1 | ZSBIO | 1 : 100 | Cytomembrane/cytoplasm | | CD45RO | UCHL1 | Dako | 1 : 100 | Cytomembrane | | CD56 | IB6 | Gene Company | 1 : 100 | Cytomembrane | | CD79a | HM47/A9 | Shanghai Long Island | 1 : 100 | Cytomembrane | | Cyclin D1 | SP4 | Gene Company | 1 : 80 | Nuclei | | EMA | GP1.4 | Shanghai Long Island | 1 : 200 | Cytomembrane | | Granzyme-B | GZB01 | MXBIO | 1 : 50 | Cytoplasm | | MUM1 | Mum1p | MXBIO | Ready to use | Nuclei | | MYC | Y69 | ZSBIO | 1 : 150 | Nuclei | | Ki67 | MIB-1 | Gene Company | 1 : 150 | Nuclei | | Perforin | MRQ-23 | ZSBIO | 1 : 20 | Cytoplasm | | TIA-1 | 2G910F5 | ZSBIO | 1 : 100 | Cytoplasm |
|
|
